Digital Health and Telemedicine ETF
- International shares
Exposure to a portfolio of leading global digital healthcare companies
Overview
Fund objective
EDOC aims to track the performance of an index (before fees and expenses) that provides exposure to a portfolio of leading global digital healthcare companies.
Benefits of EDOC
-
Access the growth potential of the digital health revolution
Healthcare spending is projected to rise as populations age and income levels increase. Spending is also likely to increasingly favour digital health solutions over the traditional way of delivering healthcare.
-
Exposure to leading digital healthcare companies
EDOC provides exposure to a portfolio of leading global digital healthcare companies from sectors such as telehealth, medical devices, wearables, remote patient monitoring, and digital healthcare software.
-
Convenient, cost-effective exposure
With management costs of only 0.67% p.a. (or $67 for every $10,000 invested), EDOC provides cost-effective exposure to the digital health and telemedicine thematic in a single ASX trade.*
* Certain additional costs apply. Please refer to PDS.
There are risks associated with an investment in EDOC, including market risk, sector risk, international investment risk risk and concentration risk. Investment value can go up and down. An investment in the Fund should only be considered as a part of a broader portfolio, taking into account your particular circumstances, including your tolerance for risk. For more information on risks and other features of the Fund, please see the Product Disclosure Statement and Target Market Determination, both available on this website.
How to invest
- You can buy or sell units just like any share on the ASX.
- Fund requires no minimum investment.
Key facts
Pricing information
| Current price | |
|---|---|
| Last trade* | |
| % Change (prev day) | |
| Bid (delayed) | |
| Offer (delayed) | |
* Data is delayed by at least 20 minutes.
| NAV | |
|---|---|
| NAV/Unit* | $8.98 |
* As at 23 April 2024
Profile
| Net assets* ($A) | $1,436,380 |
|---|---|
| Units outstanding* (#) | 160,000 |
| Management fee and cost** (p.a.) | 0.67% |
| Distribution frequency | At least annually |
| Distribution reinvestment plan (DRP) | Full or partial participation available |
| Issuer | Betashares Capital Ltd |
| Registry | Link Market Services |
* As at 23 April 2024
* As of close of previous day**Certain additional costs apply. Please refer to PDS.
Trading information
| ASX code | EDOC |
|---|---|
| Bloomberg code | EDOC AU |
| IRESS code | EDOC.AXW |
| Market makers | Susquehanna Pacific |
Index information
| Index | NASDAQ CTA Global Digital Health Index |
|---|---|
| Index provider | Nasdaq |
| Index ticker | N/A |
| Bloomberg index ticker | BEWELLAN Index |
Holdings & allocation
Portfolio holdings
| Name | Weight (%) |
|---|---|
| DEXCOM INC | 10.1% |
| BOSTON SCIENTIFIC CORP | 9.6% |
| RESMED INC | 8.7% |
| ABBOTT LABORATORIES | 8.0% |
| INSULET CORP | 7.4% |
| MASIMO CORP | 4.3% |
| EVOLENT HEALTH INC | 3.8% |
| SHOP APOTHEKE EUROPE NV | 3.8% |
| M3 INC | 3.7% |
| JD HEALTH INTERNATIONAL INC | 3.5% |
* As at 26 April 2024. Excludes cash
Sector allocation
| Health Care Equipment | 53.4% |
|---|---|
| Health Care Technology | 17.0% |
| Drug Retail | 13.4% |
| Health Care Services | 11.7% |
| Managed Health Care | 4.2% |
| Insurance Brokers | 0.3% |
* As of 28 March 2024
Country allocation
| United States | 81.2% |
|---|---|
| China | 7.8% |
| Japan | 4.5% |
| Netherlands | 4.1% |
| Switzerland | 1.5% |
| South Korea | 0.6% |
| Other | 0.3% |
* As of 28 March 2024
Performance
Fund returns after fees (%)
| Fund | Index | |
|---|---|---|
| 1 month | 3.15% | 3.17% |
| 3 months | 1.28% | 1.39% |
| 6 months | 8.35% | 8.72% |
| 1 year | -13.68% | -13.07% |
| 3 year p.a. | - | -13.61% |
| 5 year p.a. | - | 3.61% |
| 10 year p.a. | - | - |
| Since inception (p.a.) | -10.97% | -10.33% |
| Inception date | 28-Mar-22 | - |
* As at 28 March 2024.
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.
Chart
Past performance is not indicative of future performance. Please refer to "Fund returns after fees" for additional information regarding performance/return information.
Distributions
Yield information
| 12 mth distribution yield* | - |
|---|
*As at 28 March 2024. Yield is calculated by summing the prior 12-month per unit distributions divided by the closing NAV per unit at the end of the relevant period. Yield will vary and may be lower at time of investment. Past performance is not indicative of future performance.
You can elect DRP by logging into Link’s Investor Centre. Once you are logged in, please proceed to the 'Payments and Tax' tab and select ‘Reinvestment Plans'.
Recent distributions
| Ex Date | Record Date | Payment Date | Distribution Unit ($) | Annual Distribution Return (%) (1) |
|---|---|---|---|---|
| 2-Jan-24 | 3-Jan-24 | 17-Jan-24 | - | - |
| 3-Jul-23 | 4-Jul-23 | 18-Jul-23 | - | - |
| 3-Jan-23 | 4-Jan-23 | 18-Jan-23 | - | - |
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.